Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 1134792 records

$199,812.00

Nov 1, 2016
Description:

Child developmental health, maternal psychosocial distress, and health system costs at 18 months corrected age: Effectiveness of a cluster randomized controlled trial of Family Integrated Care in Level II NICUs

Organization: Canadian Institutes of Health Research
Location: Calgary, Alberta, CA T2N 1N4

$250,000.00

Nov 1, 2016
Description:

The role of envelope glycosylation on HIV-1 transmission efficiency

Organization: Canadian Institutes of Health Research
Location: London, Ontario, CA N6A 3K7

$250,000.00

Nov 1, 2016
Description:

The role of CD71+ cells in HIV pathogenesis: Reactivation of latent HIV by CD71+ cells and Galectin-9

Organization: Canadian Institutes of Health Research
Location: Edmonton, Alberta, CA T6G 2E1

$109,216.00

Nov 1, 2016
Description:

Immuno-modulatory HIV-1 nanoparticles as a novel vaccine platform

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 1X8

$249,319.00

Nov 1, 2016
Description:

Understanding how HIV integrase inhibitors, integrase inhibitor resistance mutants and non-B DNA reprogram integration site targeting for latency

Organization: Canadian Institutes of Health Research
Location: London, Ontario, CA N6A 3K7

$248,700.00

Nov 1, 2016
Description:

Examining the role of plasmacytoid dendritic cells in the control of HIV infection using humanized mice

Organization: Canadian Institutes of Health Research
Location: Montréal, Quebec, CA H2W 1R7

$198,330.00

Nov 1, 2016
Description:

Biostatistical methods for estimating the cumulative impact of environmental contaminant exposures on preterm birth

Organization: Canadian Institutes of Health Research
Location: Burnaby, British Columbia, CA V5A 1S6

$249,900.00

Nov 1, 2016
Description:

Radiotheraphy strategies to eliminate T cells latently infected with HIV provirus

Organization: Canadian Institutes of Health Research
Location: Vancouver, British Columbia, CA V6T 1Z1

$198,942.00

Nov 1, 2016
Description:

Development of therapeutics for prevention and treatment of pre-eclampsia: One of the leading causes of preterm birth in Canada.

Organization: Canadian Institutes of Health Research
Location: Kingston, Ontario, CA K7L 3N6

$234,375.00

Nov 1, 2016
Description:

Therapeutic effects of intranasal insulin on HIV-associated neurocognitive disorder

Organization: Canadian Institutes of Health Research
Location: Edmonton, Alberta, CA T6G 2E1